Table 2.
Estimated means and change on primary and secondary outcomes
Outcome | Time | Estimated mean (SE) | Estimated change (95% CI) |
d | P value |
BDD-YBOCS | Pre | 28.72 (1.35) | |||
Mid | 20.6 (1.43) | −8.12 (−10.93 to −5.32) | −1.66 | 0.001 | |
Post | 16.09 (1.52) | −12.63 (−15.61 to −9.65) | −2.57 | 0.001 | |
Follow-up | 17.01 (1.43) | −11.71 (−14.52 to −8.91) | −2.39 | 0.001 | |
MADRS-S | Pre | 20.16 (1.59) | |||
Week 1 | 19.54 (1.08) | −0.62 (−2.74 to 1.51) | −0.07 | 0.57 | |
Week 2 | 17.02 (1.09) | −3.14 (−5.28 to −1) | −0.38 | 0.004 | |
Week 3 | 17.24 (1.11) | −2.91 (−5.1 to −0.73) | −0.35 | 0.01 | |
Week 4 | 16.15 (1.16) | −4.01 (−6.29 to −1.72) | −0.48 | 0.001 | |
Week 5 | 16.8 (1.13) | −3.35 (−5.57 to −1.14) | −0.4 | 0.003 | |
Week 6 | 16.7 (1.23) | −3.46 (−5.86 to −1.06) | −0.42 | 0.005 | |
Week 7 | 14.76 (1.25) | −5.4 (−7.84 to −2.95) | −0.65 | 0.001 | |
Week 8 | 15.37 (1.28) | −4.78 (−7.29 to −2.28) | −0.58 | 0.001 | |
Week 9 | 14.88 (1.25) | −5.27 (−7.72 to −2.82) | −0.63 | 0.001 | |
Week 10 | 16.37 (1.21) | −3.78 (−6.14 to −1.42) | −0.46 | 0.002 | |
Week 11 | 13.5 (1.34) | −6.66 (−9.28 to −4.03) | −0.8 | 0.001 | |
Post | 13.36 (1.17) | −6.8 (−9.08 to −4.51) | −0.82 | 0.001 | |
Follow-up | 12.37 (1.3) | −7.78 (−10.34 to −5.23) | −0.94 | 0.001 | |
BABS | Pre | 14.75 (1.06) | |||
Post | 10.1 (1.18) | −4.65 (−6.96 to −2.34) | −0.98 | 0.001 | |
Follow-up | 10.72 (1.1) | −4.03 (−6.19 to −1.87) | −0.85 | 0.001 | |
GAF | Pre | 57.34 (1.73) | |||
Post | 67.43 (2.2) | 10.08 (5.76 to 14.4) | 0.94 | 0.001 | |
Follow-up | 61.55 (2.07) | 4.21 (0.15 to 8.27) | 0.39 | 0.048 |
P values: estimated change.
BABS, Brown Assessment of Beliefs Scale; BDD-YBOCS, Body Dysmorphic Disorder modification of the Yale-Brown Obsessive Compulsive Scale; d, Cohen’s d; GAF, Global Assessment of Functioning; MADRS-S, Montgomery-Åsberg Depression Rating Scale–Self-Rated.